Evicenter
MarkdownMedical informationP&T meetings
Lonimecgene renparvovec (TSHA-102)

Rett syndrome

Launch
Not announced
Last updated
199 sources

Product information and disease descriptionProduct description

Product information

75 evidence topics · 35 sources

Average sales price and wholesale acquisition cost

Not applicable.

Contraindications/Warnings/Precautions/Adverse effects
Warnings and precautions

Not applicable.

Effect of Lonimecgene renparvovec on quality measures
Product-specific effect on quality measures

No evidence found.